YOLFTbeta
20

Telcon Inc

200230 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

1,887.00KRW+14.00 (+0.75%)

Price History

Full chart

Market Stats

Previous Close1,873.00
Open1,895.00
Day Range1,877.00 – 1,896.00
52-Week Range1,700.00 – 13,210.00
Volume16.81K
Market Cap16.39B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.41
50-Day Avg2,188.08
200-Day Avg5,564.45

About

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOJin-Hun Lim
  • Employees126
  • Headquarters54, Gongse-ro, Yongin-si, South Korea, Korea
  • Websitehttps://www.telcon.co.kr

Leadership

  • Jin-Hun LimChief Executive Officer and President

Financials

Income Statement

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue46.64B58.76B28.54B29.84B41.15B57.71B56.59B33.14B37.84B27.83B36.31B37.87B43.16B
Growth (%)-+25.98%-51.42%+4.55%+37.90%+40.24%-1.94%-41.44%+14.18%-26.46%+30.46%+4.29%+13.99%
Cost of Revenue34.26B46.01B23.96B26.77B36.61B48.20B41.44B25.85B28.72B22.17B26.72B27.56B32.96B
Gross Profit12.37B12.36B4.58B3.07B4.54B9.51B15.15B7.29B9.13B5.66B9.59B10.31B10.20B
Gross Margin26.53%21.03%16.05%10.30%11.03%16.48%26.77%22.00%24.11%20.35%26.41%27.23%23.64%
Operating Expense2.52B4.29B4.87B13.44B17.96B26.42B30.28B51.35B14.78B27.13B9.95B10.38B9.49B
Operating Income9.86B8.07B-286.06M-10.37B-13.43B-16.91B-15.13B-44.05B-5.65B-21.47B-359.21M-70.55M718.59M
Operating Margin21.14%13.73%-1.00%-34.74%-32.63%-29.31%-26.74%-132.93%-14.94%-77.14%-0.99%-0.19%1.66%
EBITDA----------36.77B18.80B-18.23B-1.79B
EBITDA Margin----------132.13%51.77%-48.15%-4.16%
Net Income7.89B6.74B348.21M-3.44B-16.44B-13.75B-52.65B-43.05B-23.10B-42.08B13.91B-26.32B-11.46B
Net Income Margin16.92%11.47%1.22%-11.52%-39.95%-23.83%-93.03%-129.91%-61.04%-151.22%38.30%-69.51%-26.54%
R&D-1.55B1.75B2.77B5.33B3.80B-1.82B1.64B1.21B733.17M722.94M699.14M
R&D as % of Total Revenue-2.64%6.12%9.29%12.95%6.59%-5.48%4.32%4.34%2.02%1.91%1.62%
Interest Expense00000002.85B7.70B1.06B603.58M3.76B4.81B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%8.60%20.35%3.82%1.66%9.93%11.15%

Balance Sheet

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets32.20B47.76B48.15B124.51B209.64B181.79B131.65B185.05B168.03B119.25B140.41B153.59B156.67B
Total Liabilities9.69B4.55B4.16B58.55B101.96B27.76B17.63B93.71B61.45B35.13B35.47B70.45B47.85B
Total Equity-43.21B43.99B65.96B107.69B154.03B114.02B91.34B106.58B84.12B104.46B82.83B108.50B
Cash12.41B21.08B18.05B8.86B16.44B7.24B15.72B24.54B2.35M3.91M8.52B3.31B26.12B
Total Debt---11.62B17.12B-1.78B2.60B-----
Net Debt-------61.48B30.80B19.12B17.92B51.36B6.18B

Cash Flow

Currency: KRW2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.62B1.47B2.27B-4.95B-9.87B-9.25B5.01B2.80B-358.56M-2.09B-1.13B1.22B1.67B
Investing Cash Flow-3.47B-4.66B-4.18B-50.06B-82.21B-57.42B-118.05M-62.08B879.02M-7.89B-10.52B--
Financing Cash Flow858.00M11.83B-1.12B47.68B99.24B94.29B3.80B68.33B-1.89B-3.44B10.45B--
Capital Expenditure870.00M803.04M274.11M31.70B10.64B2.65B957.11M1.13B2.25B819.43M1.90B4.97B319.81M
Free Cash Flow------5.30B4.80B-11.89B-2.84B-3.03B-3.76B1.35B
FCF to OCF------105.76%171.12%3316.63%135.63%267.26%-308.17%80.81%

Earnings

Report DateMay 18, 2015Aug 14, 2015Nov 13, 2015Jan 26, 2016May 13, 2016Aug 12, 2016Nov 14, 2016Mar 3, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Mar 9, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 8, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 28, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 22, 2021May 13, 2021Aug 13, 2021Sep 30, 2021Mar 8, 2022May 13, 2022Aug 12, 2022Sep 30, 2022Mar 21, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 19, 2024May 16, 2024Aug 14, 2024Nov 12, 2024Mar 17, 2025May 14, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------
EPS Actual6.542.501.90-4.00-9.25-8.5040.38-68.69-41.01-146.48-81.0617.39-15.92-153.43-32.0920.541.8811.75-41.23-604.55-381.08-3490.554531.59-527.5630.7458.78-4184.90-197.22-95.47-216.21-2395.912.38429.40-246.78-90.4514.22-62.72-84.5325.11-1015.21-1217.15-403.41-460.871437.83-1673.68-1948.83
Surprise----------------------------------------------
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-------Pre-marketPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-----

Key Statistics & Ratios

Market Cap16.39B
Enterprise Value42.17B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.27
Price / Book0.21
Revenue (TTM)61.78B
Gross Profit (TTM)21.50B
EBITDA6.29B
Profit Margin-28.29%
Operating Margin-2.78%
Return on Equity-32.70%
Return on Assets0.15%
Shares Outstanding7.14M
Shares Float2.47M
Beta0.41
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 30, 20261:10
  • Aug 22, 2025959692:319897
  • Jul 4, 2025617:499
  • Dec 30, 20241:10
  • Sep 7, 20165:1
  • Jul 11, 20162:1